SCHEMBL9563489

SCHEMBL9563489

C=C(Cn1cnc2c(N)ncnc21)CC(F)(F)O[PH](=O)OC(F)(F)CC(=C)Cn1cnc2c(N)ncnc21

nearest known ligand 0.48

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ ADORA2A P29274 8/20 0.48
▸ ADORA1 P30542 4/20 0.48
▸ PI4KA P42356 3/20 0.48
▸ PI4K2B Q8TCG2 3/20 0.48
▸ PI4K2A Q9BTU6 3/20 0.48
▸ PI4KB Q9UBF8 3/20 0.48
▸ EGFR P00533 3/20 0.47
▸ NSD2 O96028 1/20 0.44
▸ NSD3 Q9BZ95 1/20 0.44
▸ ALDH1A1 P00352 1/20 0.44
▸ SRC P12931 1/20 0.43
▸ KDR P35968 1/20 0.43
▸ ADORA2B P29275 1/20 0.43
▸ FGFR1 P11362 1/20 0.43
▸ SLC22A6 Q4U2R8 1/20 0.43
▸ AHCY P23526 4/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9563482 0.81 CYP3A4 (0.49) ADORA2AADORA1PI4KAPI4K2BPI4K2A
SCHEMBL9563486 0.74 AHCY (0.55) ADORA2AADORA1PI4KAPI4K2BPI4K2A
SCHEMBL7199253 0.73 ADORA2A (0.62) ADORA2AADORA1PI4KAPI4K2BPI4K2A
SCHEMBL1673251 0.70 EGFR (0.70) ADORA2AADORA1PI4KAPI4K2BPI4K2A
SCHEMBL17165347 0.70 EGFR (0.66) ADORA2AADORA1PI4KAPI4K2BPI4K2A
SCHEMBL27713663 0.69 EGFR (0.64) ADORA2AADORA1PI4KAPI4K2BPI4K2A
SCHEMBL6694591 0.69 EGFR (0.60) ADORA2AADORA1PI4KAPI4K2BPI4K2A
SCHEMBL9435719 0.69 PI4KA (0.62) ADORA2AADORA1PI4KAPI4K2BPI4K2A
SCHEMBL13662886 0.68 SLC22A6 (0.63) ADORA2AADORA1PI4KAPI4K2BPI4K2A
SCHEMBL12126374 0.68 ADORA2A (0.54) ADORA2AADORA1PI4KAPI4K2BPI4K2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0531597-A1 Novel unsaturated acyclic phosphonate derivatives of purine and pyrimidine MERRELL DOW PHARMACEUTICALS INC. (US) 1993-03-17 — — EP disclosed
Send feedback